The discourse in America right now over drug re-importation schemes involving Canada and Europe is largely misguided. The issues raised concerning safety are barely worth mentioning and easily mended with factory inspections. What is needed is a serious discussion of the economics of the health industry and how the market has begun to fail America.Laura...